SOCS3, a cytokine signaling inhibitor, is involved in the regulation of inflammatory processes and activation of JAK/STAT signaling, and SOCS3 is involved in the regulation of inflammation in RA through the cholinergic anti-inflammatory pathway [62]. This evidence concerns the gene SOCS3 and rheumatoid arthritis.